RxDoctor Payments Data

Parham Mora, MD

Surgery · Prattville, ALNPI 1417915679

Payments from drug & device makers

What this record shows

This record is dominated by education: $10,000 of the $16,307 with a category attached, or 61.3%. Intuitive Surgical accounts for 78.2% of it on its own, with 19 other manufacturers making up the rest. Reporting peaked in 2019 at $5,303 and has fallen 95.0% since, to $266 in 2025. Among surgery clinicians in AL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$16,307in general payments, 2019–2025

Across 99 payments — averaging $164.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$13K
  • Applied Medical Resources Corporation$1K
  • Asensus Surgical, Inc.$763
  • Teleflex LLC$425
  • Novo Nordisk$190
  • Davol Inc.$151
  • plus $845 from 14 others

What the payments were for

  • Travel & lodging$2,78417%
  • Food & beverage$3,52322%
  • Education$10,00061%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$16,307 in reported general payments places this provider in the 90th percentile of 382 surgery providers in Alabama.

See all surgery providers in Alabama

Medicare billing

Part B allowed, 2024
$78,748
Medicare patients
212
Services billed
489

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide78$94,788
MounjaroTirzepatide83$89,781
Esomeprazole Magnesium170$5,581
Sucralfate33$812
Pantoprazole Sodium38$538
Omeprazole39$388
Ondansetron OdtOndansetron33$195
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen84$189
Scopolamine12$165
Gabapentin76$156
Topiramate30$151
Ondansetron Hcl23$130
Famotidine14$116
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim11$101
Metoclopramide Hcl12$75

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$190$94,78878 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 382 surgery providers in Alabama.

Other surgery in Prattville

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →